Magnetocardiography identifies infarction features in MINOCA patients with normal ECG findings
Magnetocardiography shows heart damage when standard tests are normal
This case series explores the use of magnetocardiography (MCG) for identifying myocardial infarction in patients with non-ST-segment elevati…
New imaging may help identify heart attacks in patients whose standard EKG results appear normal, offering a potential new tool for clearer …
21% hypertension prevalence in transgender adults: meta-analysis of cardiovascular morbidities
Transgender adults face high rates of heart disease
This meta-analysis of observational studies reports pooled prevalence of major cardiovascular morbidities among transgender adults aged ≥18 …
One in five transgender adults has high blood pressure, and many have heart disease, a new analysis finds.
Macrophage migration inhibitory factor serves as a potential biomarker and therapeutic target for atrial fibrillation
Protein levels may predict heart failure and stroke risks
This systematic review synthesizes evidence regarding macrophage migration inhibitory factor (MIF) in the context of atrial fibrillation and…
A specific protein called MIF is linked to heart damage and can help doctors predict serious complications like stroke or heart failure.
Finerenone reduces mortality and heart failure risk (HR 0.644) in post-AMI patients
Finerenone may lower heart failure risk after heart attack
This retrospective cohort study of 1,012 adult patients with AMI found that finerenone initiation within 6 months was associated with a lowe…
A new look at real-world data suggests the drug finerenone could protect hearts and kidneys in patients following a heart attack.
Immune-stromal imbalance drives heart failure after myocardial infarction, systematic review finds
Immune cell balance determines if heart tissue heals or fails
This systematic review maps the bidirectional regulatory network between immune cells and cardiac stromal cells after myocardial infarction.…
A new map of how immune cells talk to heart tissue helps explain why some hearts heal after a heart attack while others develop failure.
Tocilizumab shows early anti-inflammatory effects but no significant clinical benefit in STEMI or NSTEMI
Tocilizumab shows early signs of heart protection in heart attacks
This meta-analysis of randomized controlled trials evaluated tocilizumab for patients with STEMI and NSTEMI. While the intervention showed a…
A new review looks at how the drug tocilizumab affects patients with heart attacks, showing some early signs of reduced inflammation.
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings
SGLT2 inhibitors show promise for heart failure and diabetes
This narrative review examines the cardiovascular and metabolic effects of SGLT2 inhibitors, specifically empagliflozin and dapagliflozin. T…
New evidence shows how SGLT2 inhibitors may protect the heart and manage risks for patients with type 2 diabetes and heart failure.
Current literature lacks research on myocardial infarction warning signs within transgender and gender diverse populations in the United States
No clear guide exists for transgender heart attack warning signs in the United States
A brief review highlights a critical gap in understanding heart attack symptoms for transgender and gender diverse individuals. More researc…
A review found no current research on heart attack warning signs for transgender people, leaving them without standard heart health educatio…
Polygenic scores link to atherosclerosis and ischemic heart disease in Russian populations
Genetic markers help predict heart disease risk for Russian men and women
This meta-analysis review examines genetic predictors of atherosclerosis, ischemic heart disease, and myocardial infarction in a Russian pop…
A large study found specific genes linked to cholesterol levels in Russian people. These genetic scores can help doctors check heart disease…
Baduanjin exercise practice improves outcomes for patients with acute myocardial infarction undergoing percutaneous coronary intervention procedures
Baduanjin exercise improves heart recovery and mood after heart attack surgery
A systematic review and meta-analysis of 1,293 patients with acute myocardial infarction undergoing percutaneous coronary intervention found…
A meta-analysis shows Baduanjin exercise improved heart function, walking distance, and mood in patients recovering from heart attacks and s…
Docetaxel chemotherapy is highly suspect for causing acute myocardial infarction in a low-risk triple-negative breast cancer patient
Docetaxel chemotherapy linked to rare heart attack in breast cancer patient
This case report and literature review examines acute myocardial infarction following docetaxel chemotherapy in a patient with triple-negati…
A rare heart attack occurred after docetaxel chemotherapy in a patient with triple-negative breast cancer. This case review suggests the dru…
Research across Myocardial ischemia
Related studies from across the Myocardial ischemia family.
Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
Physiology guided heart procedures show lower risk of major events
Physiology-guided revascularization significantly reduces major adverse cardiac events and improves safety profiles compared to traditional …
A large international trial shows that using functional imaging to guide heart artery procedures may lower the risk of stroke and heart atta…
Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding
Trial shows ticagrelor monotherapy may reduce bleeding after heart attack
This pilot study compared ticagrelor monotherapy against ticagrelor plus aspirin in patients with STEMI after primary PCI. The trial reporte…
A pilot study suggests that using ticagrelor alone after a heart attack may reduce specific types of bleeding compared to a dual-drug approa…
High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
High dose statins may improve outcomes for heart attack patients
This meta-analysis of 1862 patients with STEMI undergoing primary PCI indicates that high-dose statin preloading is associated with improved…
A high dose of statins before a heart procedure may improve blood flow and lower death rates for patients with a heart attack.
Ticagrelor monotherapy after primary PCI shows 3.1% MACCE versus 2.0% in DAPT group
Trial shows ticagrelor alone may reduce bleeding after heart attack
This pilot randomized controlled trial of 200 STEMI patients compared ticagrelor monotherapy to ticagrelor plus aspirin (DAPT) after primary…
A new trial looks at whether using one blood thinner instead of two can reduce bleeding risks for patients after a heart attack.
Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients
New stenting technique improves blood flow after heart attacks
This multicenter randomized trial of 607 patients undergoing primary PCI for STEMI found that a pressure optimization protocol (POP) signifi…
A new pressure optimization method during heart surgery helps restore blood flow faster and reduces the need for extra procedures.
Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
Intracoronary Thrombolysis Linked to Lower Risks After Heart Attack
This meta-analysis evaluated the impact of adjunctive intracoronary thrombolysis during primary percutaneous coronary intervention for patie…
Adding intracoronary thrombolysis during heart procedures may lower the risk of major complications and improve blood flow for patients with…
Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
Persistent heart muscle damage after heart attack increases risk
This meta-analysis of 2180 patients with STEMI identifies persistent microvascular obstruction as a significant prognostic indicator. Persis…
Patients with lasting microvascular obstruction after a heart attack face higher risks of death and major complications compared to those wi…
Intracoronary mesenchymal stem cell administration improves left ventricular ejection fraction following ST-segment elevation myocardial infarction
Stem cells improve heart function after heart attack but not outcomes
This meta-analysis of 8 randomized controlled trials found that intracoronary mesenchymal stem cell (MSC) administration significantly impro…
New data shows stem cell treatment improves heart muscle pumping power after a heart attack, though it does not yet reduce hospital visits o…
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Transvalvular microaxial flow pump plus PCI does not reduce infarct size in anterior STEMI
Trial shows microaxial flow pump does not reduce heart damage
This randomized controlled trial of 527 adults with acute anterior STEMI found that LV unloading with a transvalvular microaxial flow pump f…
A clinical trial found that using a transvalvular microaxial flow pump before heart surgery did not reduce the size of heart tissue damage.
Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
Timing of heart surgery does not change survival for a specific heart attack group
This meta-analysis reviewed 5077 patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease comparing …
A large review found that waiting for staged heart surgery did not improve survival or reduce heart attacks compared to immediate surgery fo…
Complete revascularization shows high probability of benefit for NSTEMI patients with multivessel disease
Complete revascularization shows high probability of benefit for NSTEMI patients with multivessel disease
This Bayesian re-analysis of a randomized trial evaluated complete versus culprit-only revascularization in patients with non-ST-elevation m…
A Bayesian re-analysis suggests complete revascularization offers a high probability of clinically meaningful benefit compared to treating o…
Questions about Myocardial Infarction
Will a special breathing machine help if I have sleep problems after my heart attack?
Yes, a special breathing machine (ASVmv) can reduce nighttime oxygen drops in heart attack patients with sleep-disordered breathing, but it's not a standard treatment for all sleep problems after a heart attack.
Full answer →Can I choose between moderate or high-intensity exercise to recover from my heart attack?
Both moderate and high-intensity exercise similarly improve heart function after a heart attack, but you should start with moderate intensity and get your doctor's approval before increasing intensity.
Full answer →Does my kidney number creatinine level affect my risk after a heart attack procedure?
Yes, higher creatinine levels are linked to a greater risk of adverse events after a heart attack procedure, especially if you also have anemia.
Full answer →How do artificial intelligence tools compare to doctors for predicting heart attack biomarkers?
AI tools can match or slightly outperform doctors in predicting heart attack biomarkers, but most studies lack real-world validation.
Full answer →Do beta-blockers reduce my risk of death if my heart function is normal after MI?
For patients with normal heart function after MI, beta-blockers do not appear to reduce the risk of death or recurrent heart attack based on recent large trials.
Full answer →Does having a specific type of myocardial injury increase my risk of future heart events?
Yes, the type of myocardial injury matters: type 1 MI carries the highest risk of future heart events, but type 2 MI and acute/chronic myocardial injury also increase risk compared to no injury.
Full answer →